Quest Diagnostics Increases Share Repurchase by $750M

Quest Diagnostics Incorporated DGX announced earlier that its Board of Directors increased the company's share repurchase authorization by $750 million. This action increases the current share repurchase authorization to $1 billion. During 2010, the company repurchased approximately 15 million shares of common stock for $750 million. The company had 171 million shares outstanding as of December 31, 2010.